Patent applications published 12 May 2010
Selected patent applications from the weekly European Patents Bulletin
- Antimicrobial constructs
Allvivo Vascular; The State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University 2182798*
- Supramolecular functionalisation of graphitic nanoparticles for drug delivery
The Board of Trustees of the Leland Stanford Junior University 2182799*
- Fungicidal N-cycloalkyl-benzyl-thiocarboxamides or N-cycloalkyl-benzyl-N’-substituted-amidine derivatives
Bayer CropScience 2182800*
- Pyrone analogue compsns and methods
Limerick BioPharma 2182801*
- 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder
Synosia Therapeutics 2182803*
- Methods for treating dependence
Synosia Therapeutics 2182804*
- Antiviral drugs for treatment of areavirus infection
Siga Technologies 2182805*
- Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
Jenrin Discovery 2182807*
- Pyridine compounds for inflammation and immune-related uses
Synta Pharmaceuticals 2182808*
- Therapeutic isoxazole compounds
Helicon Therapeutics 2182809*
- Compsns and methods for treatment and prevention of osteoarthritis
Nucitec 2182810*
- Antimicrobial compsns
Virox Technologies 2182811*
- Methods for making drug-eluting medical devices
Boston Scientific Scimed 2182897*
- Pharmaceutical compsn for topical application of poorly soluble compounds
Intendis 2182918*
- Compsns, uses and method of making wound care products from naturally occurring food ingredients
Bill McAnalley and Associates 2182919*
- Stable liquid pharma compsn based on trazodone
Aziende Chimiche Riunite Angelini Francesco 2182920*
- Antigen-adjuvant compsns and methods
Sanofi Pasteur 2182922*
- Virosomes comprising haemagglutinin derived from an influenza virus produced in a cell line, compsns, methods of manufacturing, use thereof
Pevion Biotech 2182923*
- Methods for imaging using improved nanoparticulate contrast agents
Nanoscan Imaging 2182924*
- Pharmaceutical compsn and process for making thereof
Cipla 2182925*
- Anti-HIV formulations comprising darunavir
Tibotec Pharmaceuticals 2182926*
- Pharmaceutical compsns of candesartan
Teva Pharmaceutical Industries 2182927*
- Formulations of nonopioid and confined opioid analgesics
Abbott 2182928*
- Duloxetine formulations
Synthon 2182929*
- Method and arrangement for forming variable colour pharmaceutical products
BPSI Holdings 2182930*
- Derivatised polysaccharide material for the topic antibacterial activity
Humanitas Mirasole; Politecnico di Milano; Istituto di Richerce Chimiche e Biochimiche Giuliana Ronzoni 2182931*
- Transdermal administration of (2S)-4E)-N-methyl-5-(3-(5-isopropoxypyrdin)yl)-4-penten-2-amine
Targacept; AstraZeneca 2182932*
- Novel medicament in powder form comprising tiotropium and salmeterol, and lactose as excipient
Boehringer Ingelheim International 2182933*
- Uses of trientine and penicillamine as countermeasures to metal contamination
Aton Pharma 2182934*
- The use of benzamide derivatives for the treatment of CNS disorders
F Hoffmann-La Roche 2182935*
- Substrate reduction therapy
The Chancellor, Masters and Scholars of the University of Oxrod; The Government of the USA as represented by the Secretary of the Department of Health and Human Services 2182936*
- An antiviral compsn
Malaysian Palm Oil Board 2182937*
- Methods for promoting wakefulness
Colucid Pharmaceuticals 2182938*
- Compsns including triciribine and taxanes and methods of use thereof
Vioquest Pharmaceuticals 2182939*
- Use of tetrahydrocannabinol and/or cannbidiol for the treatment of inflammatory bowel disease
GW Pharma 2182940*
- Multikinase inhibitors for use in the treatment of cancer
Eisai R&D Management 2182941*
- Pharmaceutical compsn effective against biofilms
Helmholtz-Zentrum für Infektionsforschung 2182942*
- Methods and compsns for treating fibrosis related disorders using IL-17 antagonists
Centocor Ortho Biotech 2182943*
- Compsns and methods for treating immunological and inflammatory diseases and disorders
Lexicon Pharmaceuticals 2182944*
- Substituted azabicyclo [4.1.0] heptane compounds for use as monoamine reuptake inhibitors
Glaxo Group 2182946*
- Compsns with enhanced bioavailability and fast acting inhibitor of gastric acid secretion
Yale University 2182947*
- Use of imidazoquinolines for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
Novartis 2182948*
- (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzo-furan-2-carboxamide, novel salt forms and methods of use thereof
Targacept 2182949*
- Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
Helperby Therapeutics 2182950*
- Treatment of paediatric tumours
SIGMA-TAU Industrie Farmaceutiche Riunite 2182951*
- Treatment of post-traumatic stress disorder
Synosia Therapeutics 2182952*
- New pyrazol derivatives
F Hoffmann-La Roche 2182953*
- Use of nor-bile acids in the treatment of arteriosclerosis
Medizinische Universität Graz 2182954*
- Method of manufacture of compressed pharmaceutical formulation containing tibolone
Zentika 2182955*
- Salicylanilide modified peptides for use as oral therapeutics
The Regents of the University of California 2182956*
- Phosphorylated pyrone analogues and methods
Limerick BioPharma 2182957*
- Pharmaceutical compsn and pharmaceutical kit for the treatment of hepatocellular carcinoma
Alma Mater Studorium - Universia’ di Bologna 2182958*
- Compsn and treatment
Cornelli, Umberto 2182959*
- Compounds, formulations and methods for reducing skin wrinkling, creasing and sagging
Galderma Laboratories 2182960*
- Prevention of gastric ulcers by carbon monoxide
Alfama - Investigaçao e Desenvolvimento de Produtos Farmaceuticos 2182961*
- pondias mombin L extract and methods of extracting and using such extract
Selvamedica 2182962*
- Herbal compsn on the basis of extracts of Foeniculum vulgare, Murraya koenigii and Triphala
Delhi Institute of Pharmaceutical Sciences and Research (DISPAR); Promed Exports Private Ltd 2182963*
- Use of an active principle from flax for use in a compsn for activating cytochrome C
Société d’Extraction des Principes Actifs 2182964*
- Extracts of Ligustrum lucidum and uses thereof
Bionovo 2182965*
- The use of extracts or materials extracted from Piper cubeba L as an effective component in a drug for the treatment of cancer diseases
Viridus Pharmaceutical 2182966*
- Process for preparing vitus vinifera pip extract and pharmaceutical compsn for preventing or treating rheumatoid arthritis comprising the same
Catholic University Industry Academic Cooperation Foundation; H.I. Genomics 2182967*
- Methods of treating and protecting against human immunodeficiency virus
Duke University 2182968*
- A micro-RNA family that modulates fibrosis and uses thereof
The Board of Regents of the University of Texas System 2182969*
- A memory affecting protein
The Research Foundation of the State University of New York 2182970*
- Compsns comprising human collagen and human elastin and methods for soft tissue augmentation
Humacyte 2182971*
- Peptide sequences and compsns
Peptcell 2182972*
- Chemokine analogues
Ipsen Pharma 2182973*
- Cyclic azapeptides as integrin markers
Siemens Medical Solutions USA 2182974*
- Novel inhibitor of angiogenesis
Celecure 2182975*
- Treatment of autoimmune disease
Massachusetts Institute of Technology 2182976*
- Compsns for the treatment of stroke or cerebrovascular accidents with an endothelin B receptor agonist
Midwestern University 2182977*
- Tissue kallikrein for the treatment of diseases associated with amyloid protein
Sanomune 2182978*
- Diagnostic assay for trypanosoma cruzi infection
University of Georgia Research Foundation 2182979*
- Methods and compsns for increasing alpha-iduronidase activity in the CNS
Armagen Technologies 2182980*
- Methods and compsns for treatment and diagnosis of fibrosis, tumour invasion, angiogenesis and metastasis
Arresto Biosciences 2182981*
- Therapeutic use of anti-tweak receptor antibodies
Facet Biotech Corp 2182982*
- Treatment of amyloidogenic diseases
Janssen Alzheimer Immunotherapy; Wyeth 2182983*
- A morpholinyl anthracycline derivative combined with protein kinase inhibitors
Nerviano Medical Sciences 2182984*
- Combination therapy
The University of York 2182985*
- Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
Schering 2182986*
- Immune system modulator formulation
Medacure International 2182987*
- Radiopharmaceutical compsn
GE Healthcare 2182988*